Han Kun Law Offices

Legal Services | Mainland China, China
tel: (86 10) 8525 5500
9F, Office Tower C1, Oriental Plaza, 1 East Chang An Avenue | Beijing | Mainland China | 100738 | China

Main Contacts

Yan Wang

|
Partner

Xiaoming Li

|
Partner

Overview

Han Kun is a leading full-service law firm in China. Over the years, Han Kun has been widely recognized as a leader in complex cross-border and domestic transactions and compliance matters.

Our main practice areas include private equity, mergers and acquisitions, international and domestic capital markets, investment funds, asset management, compliance, banking and finance, aviation finance, foreign direct investment, antitrust/competition, data protection, private client/wealth management, intellectual property, bankruptcy and restructuring and dispute resolution.

We have more than 1000 professionals located in Beijing, Shanghai, Shenzhen, Hangzhou, Wuhan, Haikou, Hong Kong, Singapore, New York, Silicon Valley and London.

All our lawyers are graduates of top universities and have extensive experience in complex cross-border transactions and dispute resolution as counsel to both Chinese and foreign clients.

Our working languages include Chinese, English, Japanese, Korean and German.

Year this Office was Founded: 2004
Lawyers Worldwide: 900

Areas of Practice

Professionals

Partners

Zhiyi  Cao

Zhiyi Cao

Partner
Yinshi  Cao

Yinshi Cao

Partner
Zhiyi  Cao

Zhiyi Cao

Partner
LU  CHAI

LU CHAI

Partners
Yijun  Chao

Yijun Chao

Partner
Yang  Chen

Yang Chen

Partner
Cheng  Chen

Cheng Chen

Partner
Dafei  Chen

Dafei Chen

Partner
Lei  Chen

Lei Chen

Partner
Xiaoming  Deng

Xiaoming Deng

Partners
Yi  DING

Yi DING

Partner
Shiwen  Dong

Shiwen Dong

Partner
Wenle  Du

Wenle Du

Partner
Min  Duan

Min Duan

Partner
Rong  Fang

Rong Fang

Partner
Yin  Ge

Yin Ge

Partner
Lin  Gui

Lin Gui

Partner
Yang  Han

Yang Han

Partner
Chunyan  He

Chunyan He

Partner
Jun  He

Jun He

Partner
Rui  Huang

Rui Huang

Partner
Weiheng  Jia

Weiheng Jia

Partner
Dongni  Jiang

Dongni Jiang

Partners
Wenyu  Jin

Wenyu Jin

Partner
Tao  Lan

Tao Lan

Partner
Xun  Li

Xun Li

Partner
Jing  Li

Jing Li

Partner
Tao  Li

Tao Li

Partner
Ying  Li

Ying Li

Partners
Yipu  Li

Yipu Li

Partners
Baofu  Li

Baofu Li

Partner
Xiaoming  Li

Xiaoming Li

Partner
SHENG  LI

SHENG LI

Partner
Shijia  LI

Shijia LI

Partner
Jianhui  Li

Jianhui Li

Partner
Jun  Li

Jun Li

Partner
Andy  LIAO

Andy LIAO

Partner
Chunyao  Lin

Chunyao Lin

Partner
Zeda  Lin

Zeda Lin

Partner
Yixin  Lin

Yixin Lin

Partner
Ruina  Liu

Ruina Liu

Partner
Jiaxin  LIU

Jiaxin LIU

Partner
Jing  Liu

Jing Liu

Partner
Long  Liu

Long Liu

Partner
Paula  LIU

Paula LIU

Partner
Xiayi  Liu

Xiayi Liu

Partner
Lifeng  Lu

Lifeng Lu

Partner
Zaiguang  LU

Zaiguang LU

Partner
Rui  Luo

Rui Luo

Partner
Shaolin  Luo

Shaolin Luo

Partner
Min  Luo

Min Luo

Partner
Chen  Ma

Chen Ma

Partner
Xiu  Pei

Xiu Pei

Partner
Shuting  Qi

Shuting Qi

Partner
Wei  Quan

Wei Quan

Partners
Lu  Ran

Lu Ran

Partner
Da  Shi

Da Shi

Partners
Wei  Song

Wei Song

Partner
Haining  Song

Haining Song

Partner
Ethle  Tang

Ethle Tang

Partner
Hua  Tu

Hua Tu

Partner
Yan  Wang

Yan Wang

Partner
Huajun  Wang

Huajun Wang

Partners
Xikang  Wang

Xikang Wang

Partner
Shu  WANG

Shu WANG

Partner
Jin  Wang

Jin Wang

Partner
Xiaowei  WEI

Xiaowei WEI

Partner
Lili  WU

Lili WU

Partner
Yan  Xia

Yan Xia

Partner
Ping  Xu

Ping Xu

Partner
BING  XUE

BING XUE

Partner
Ying  YANG

Ying YANG

Partner
Li  Yang

Li Yang

Partner
Zhihao  Ye

Zhihao Ye

Partner
Feng  Ye

Feng Ye

Partner
Yang  You

Yang You

Partner
Lan  Yu

Lan Yu

Partner
Shiye  Yuan

Shiye Yuan

Partner
Liming  Yuan

Liming Yuan

Partner
Yaxing  Zhang

Yaxing Zhang

Partner
Tao  ZHANG

Tao ZHANG

Partner
Jian  Zhang

Jian Zhang

Partner
Zhao  Zhang

Zhao Zhang

Partner
Yao  Zhang

Yao Zhang

Partner
Yan  Zhang

Yan Zhang

Partner
Li  Zhang

Li Zhang

Partner
Wanmei  Zhao

Wanmei Zhao

Partners
Pei  Zhao

Pei Zhao

Partner
Ting  Zheng

Ting Zheng

Partners
Bin  ZHI

Bin ZHI

Partner
Lin  ZHOU

Lin ZHOU

Partner
Jun  ZHU

Jun ZHU

Partner
Min  Zhu

Min Zhu

Partner

Associates

Yi  Bian

Yi Bian

Associate
Yuanyuan  Chu

Yuanyuan Chu

Associate
Ying  Huang

Ying Huang

Associates
Qiongxing  WANG

Qiongxing WANG

Associate

Of Counsel

Han  Chen

Han Chen

Counsel
Dalun  Chen

Dalun Chen

Of Counsel
Junfeng  Cui

Junfeng Cui

Of Counsel
Xiao  Ding

Xiao Ding

Of Counsel
Jie (Jessie)  Dong

Jie (Jessie) Dong

Of Counsel
Xin  Du

Xin Du

Of Counsel
Wen  Feng

Wen Feng

Of Counsel
Xiao  Guo

Xiao Guo

Of Counsel
Chenchen  Jiang

Chenchen Jiang

Of Counsel
JIA(Jenny)  Li

JIA(Jenny) Li

Of Counsel
Jiankun(Rio)  Li

Jiankun(Rio) Li

Of Counsel
Zhehao  Li

Zhehao Li

Of Counsel
Qian  Li

Qian Li

Of Counsel
Kanxi  Liao

Kanxi Liao

Of Counsel
Ying  Liu

Ying Liu

Of Counsel
Jingbo  Luo

Jingbo Luo

Of Counsel
Bing  San

Bing San

Of Counsel
Huiyi  Song

Huiyi Song

Of Counsel
Yunjia  Sun

Yunjia Sun

Of Counsel
Chunzi  Wang

Chunzi Wang

Of Counsel
Xi (Cindy)  Wang

Xi (Cindy) Wang

Of Counsel
Yikai  Wang

Yikai Wang

Of Counsel
Zhenyu  Wang

Zhenyu Wang

Of Counsel
Yichen  Wu

Yichen Wu

Of Counsel
Jinli (Jolie)  Yan

Jinli (Jolie) Yan

Of Counsel
Ying  Zeng

Ying Zeng

Of Counsel
Qi  Zhang

Qi Zhang

Of Counsel
Xinfeng  Zhang

Xinfeng Zhang

Of Counsel
Yuxuan  Zhang

Yuxuan Zhang

Of Counsel
Yunzhi  Zhao

Yunzhi Zhao

Of Counsel
Hua  Zhong

Hua Zhong

Of Counsel

Other

Xiaomeng  Dong

Xiaomeng Dong

Manager of trademark application department
Michael  Jiawei He

Michael Jiawei He

Chief Marketing Officer
Chengrong (Paul)  Li

Chengrong (Paul) Li

Partner & Solicitor
Sara  Shao

Sara Shao

Business Development Manager
Tongyi  Wang

Tongyi Wang

Marketing
Jenny  Xu

Jenny Xu

Marketing

Articles

The Regulatory Data Protection System Takes Effect, Injecting New Vitality into Innovative Drug Transactions – An Analysis of the Implementation Measures for Regulatory Data Protection

On March 19, 2025, the General Affairs Department of the National Medical Products Administration ("NMPA") issued theImplementation Measures for Regulatory Data Protection (Trial, Draft for Comments)(the "Draft for Comments") and theWorking Procedures for Regulatory Data Protection (Draft for Comments)to further advance the implementation of the Regulatory Data Protection system (the "RDP System")(For an analysis of these two documents, please refer to our previously published article:A New Perspective on Innovative Drug Transactions: Analysis of the New Draft of the Regulatory Data Protection System (Bilingual))...

Spring Breeze on the Shore: New rules on RMB Cross-Border Interbank Financing and Banks' Suggested Responses

On February 26, 2026, the People's Bank of China ("PBoC") promulgated theNotice on Relevant Matters Concerning Cross-border RMB Interbank Financing Business of Banking Financial Institutions(Yin Fa [2026] No. 51, the "Notice"). Previously, on September 12, 2025, the PBoC issued theNotice of the PBoC on Relevant Matters Concerning Cross-border RMB Interbank Financing Business of Banking Financial Institutions (Draft for Comments)(the "Draft")...

VIEW ALL Han Kun Articles

Press releases

Han Kun Hong Kong advised Joint Lead Managers on Fujian Zhanglong Group Co., Ltd's CNY3,056 million Bond Issuance

Han Kun Law Offices LLP ("Han Kun Hong Kong"), acting as the international legal counsel to the Joint Lead Managers and the Trustee, advised Fujian Zhanglong Group Co., Ltd. ("Fujian Zhanglong Group") on the successful issuance of the RMB3,056 million five-year offshore sustainable bonds (the "Bonds"). The coupon rate of the 5-year Bonds is 2.35%.This issuance set a new record low for offshore Renminbi bond coupon rates among Fujian provincial state-owned enterprises, attracting broad attention and strong support from international investors, achieving 6x oversubscription, with the final coupon rate significantly tightened by 75 basis points from the initial price guidance...

Han Kun Advises CrystalO on the Collaboration and License Agreement with Almirall for the Discovery and Development of Novel Small Molecules in Medical Dermatology

On 10 August 2026, Shenzhen CrystalO Biopharma Co., Ltd. ("CrystalO") announced that it has entered into a Collaboration and License Agreement with Almirall, S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology based in Barcelona, Spain ("Almirall").Under the terms of the agreement, CrystalO will leverage its leading AI- and structure-based drug discovery platform to conduct candidate compound discovery, optimization, IND-enabling studies and early clinical development, to advance the program through proof of concept (POC) clinical testing...

VIEW ALL Han Kun Press
dots